These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38293980)

  • 1. [Effects of type 2 inflammation on bronchodilator responsiveness of large and small airways in chronic obstructive pulmonary disease].
    Xu G; Gong Z; Wang J; Ma Y; Xu M; Chen M; Hu D; Liang J; Zhao W; Zhao H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):93-99. PubMed ID: 38293980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping.
    Zhang X; Wu Z; Liu Y; Jiang S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1199-1206. PubMed ID: 32547006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of bronchodilator responsiveness of the small airway (using mid-maximal expiratory flow) in COPD - a retrospective study.
    Alobaidi NY; Almeshari MA; Stockley JA; Stockley RA; Sapey E
    BMC Pulm Med; 2022 Dec; 22(1):493. PubMed ID: 36585669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Fortis S; Quibrera PM; Comellas AP; Bhatt SP; Tashkin DP; Hoffman EA; Criner GJ; Han MK; Barr RG; Arjomandi M; Dransfield MB; Peters SP; Dolezal BA; Kim V; Putcha N; Rennard SI; Paine R; Kanner RE; Curtis JL; Bowler RP; Martinez FJ; Hansel NN; Krishnan JA; Woodruff PG; Barjaktarevic IZ; Couper D; Anderson WH; Cooper CB;
    Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
    Li M; Yang T; He R; Li A; Dang W; Liu X; Chen M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3025-3037. PubMed ID: 33244228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.
    Donohue JF; Herje N; Crater G; Rickard K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():745-51. PubMed ID: 25053884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases.
    Shi F; Qiu C; Yu J; Yang Y; Li B; Feng M; Zhang T; Liu W
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):232-239. PubMed ID: 29908540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of bronchodilator response in FEV1 and FeNO for differentiating between chronic respiratory diseases: an observational study.
    Gong Z; Huang J; Xu G; Chen Y; Xu M; Ma Y; Zhao W; Wang Y; Liang J; Ou C; Liu L; Cai S; Zhao H
    Eur J Med Res; 2024 Feb; 29(1):97. PubMed ID: 38311782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
    Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of pulmonary function and FeNO detection in early screening of patients with ACO.
    Wang J; Wang W; Lin H; Huan C; Jiang S; Lin D; Cao N; Ren H
    Exp Ther Med; 2020 Aug; 20(2):830-837. PubMed ID: 32742326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 13. Bronchodilator Reversibility in the GAN Severe Asthma Cohort.
    Milger K; Skowasch D; Hamelmann E; Mümmler C; Idzko M; Gappa M; Jandl M; Körner-Rettberg C; Ehmann R; Schmidt O; Taube C; Holtdirk A; Timmermann H; Buhl R; Korn S
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):446-456. PubMed ID: 36000830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fractional exhaled nitric oxide in bronchial inflammatory lung diseases].
    Xia Q; Pan P; Wang Z; Lu R; Hu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 39(4):365-70. PubMed ID: 24820276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-2 inflammation and lung function decline in chronic airway disease in the general population.
    Çolak Y; Afzal S; Marott JL; Vestbo J; Nordestgaard BG; Lange P
    Thorax; 2024 Mar; 79(4):349-358. PubMed ID: 38195642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of Chronic Obstructive Pulmonary Disease with High Fractional Exhaled Nitric Oxide.
    Ahn S; Kim TO; Chang J; Shin HJ; Kwon YS; Lim SC; Kim YI
    Tuberc Respir Dis (Seoul); 2020 Jul; 83(3):234-241. PubMed ID: 32610837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma.
    Kavati A; Zhdanava M; Ortiz B; Lecocq J; Schiffman B; Pilon D; Ho H; Lefebvre P; Stone B
    Clin Ther; 2019 Oct; 41(10):1956-1971. PubMed ID: 31563391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
    Pérez de Llano L; Cosío BG; Miravitlles M; Plaza V;
    Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):198-204. PubMed ID: 29229474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of ultrahigh fractional exhaled nitric oxide in predicting bronchial hyperresponsiveness in patients with suspected asthma.
    Liu J; Xu R; Zhan C; Luo W; Lai K; Zhong N; Chen W; Chen R
    Postgrad Med J; 2019 Oct; 95(1128):541-546. PubMed ID: 31296792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.